Business Categories Reports Podcasts Events Awards
Contact My Account About
Member Exclusive

Shiseido to Sell Chinese Subsidiary That Produces Aupres Brand

Published November 18, 2026
Published November 18, 2026
Aupres

Key Takeaways:

  • Shiseido to sell Chinese subsidiary that produces Aupres cosmetics to a consortium of investors led by IDG Capital.
  • The companies agreed not to renew the current joint venture, which was due to expire in December. 
  • The Japanese conglomerate will focus on nurturing core brands in the Chinese market.

In anticipation of the expiration of the current third joint venture agreement in December 2026, the parties mutually agreed not to renew it.

WHO: SLC was founded in 1991 as a joint venture between Shiseido and Beijing Liyan Co. Ltd., a subsidiary of Yiquing Group, which the Beijing Municipal Government owned. Starting in 1994, SLC manufactured and marketed Aupres skincare, which is dedicated to the Chinese market. The brand, developed to suit the skin characteristics of Chinese women, supported Shiseido's China business through a sales network centered on department stores.

IDG Capital is a leading international private equity investment firm with extensive investment experience and expertise in the consumer sector.

WHY: Under its 2030 Medium-Term Strategy, Shiseido is striving to enhance profitability, capital efficiency, and cash flow generation, ultimately maximizing corporate value. The competitive landscape in China has shifted amid the spread of e-commerce and the rise of local brands, and Aupres’ performance remained sluggish. The company will focus on nurturing core brands such as Clé de Peau Beauté and Shiseido where it has the greatest competitive advantage.

Shiseido believes that, under IDG, driving agile business execution as an independent brand will lead to sustainable growth and enhance its brand value. With IDG’s support and a new management...

×

2 Article(s) Remaining

Subscribe today for full access